Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

What kind of person are you making me.
I listened conference call and watched the slides

If you did those things then it is astonishing that you would say Paxlovid has better data given that Paxlovid failed to reduce symptoms at least to statistical significance in a similar low risk population as in SPRINT where as EDP-235 did.

How do you think I know the name of company's pipeline.

I didn't know ENTA's pipeline had a name. What is the name of ENTA's pipeline? Is it pipeline?

And there is someone who claim about Paxlovid's 2Q revenue. You can easily find him

That person is Not You though

You did NOT say about Q2's Paxlovid revenue.

Mother of God! Correct. I never mentioned Paxlovid revenues in Q2 2023 and never claimed to have mentioned it. YOU were person who mentioned the low Paxlovid revenues in Q2 and gave a figure.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172560414

Other people including myself mentioned how large Q1 2023 revenues were for Paxlovid ($4.1 billion). The difference in the two quarters was attributed by PFE to seasonality for Covid, then reiterated here on his board by a few people including myself. Nobody knows for sure if it Covid will become seasonal like the Influenza and RSV but the rise in Covid cases, not a spike, but a rise suggest there could be seasonality. Time will tell.

I do not know how long you followed Enanta.
And I don't know how well educated you are.
But this attitude is not that nice of you as a person.
You could just say what it is.
You DO NOT HAVE TO BUT.

I am sorry that you didn't like being challenged or corrected. Perhaps you should try and be less sensitive.